Mitek Lab officially signed an agency agreement with ZeptoMetrix, a subsidiary of American biotechnology company Antylia Scientific, in December.

ZeptoMetrix has gathered the world's top infectious disease scientists. Their vision is to combine high-quality products and reliable technologies to provide professional solutions to the team fighting against microbial infectious diseases and challenge to become a leader in the molecular diagnostics market. From assay development to launch, their scientific and operational teams provide their customers with comprehensive, performance-oriented and cost-effective Diagnostic Microbiology products and services that positively impact the field of clinical diagnostics and its contribution to global healthcare.

ZeptoMetrix provides a series of pathogen standards, ranging from respiratory, gastrointestinal, women's health, sexually transmitted infections to critical infectious diseases, and it is a supplier of SARS-CoV-2 standards recommended by the FDA.

ZeptoMetrix products have the following features:

• Intact microbial pellets to mimic real clinical samples (including complete genomes)

• To render non-infectious by inactivation (heat inactivation, UV inactivation, chemical inactivation)

• Easy storage condition 2-8°C, stable period of 1-2 years, easy to store and long time

• Applicable to various molecular testing platforms and assays, monitoring the whole process from extraction to amplification steps

• Traceable to WHO international standards

If you are interested, feel free to call or mail us!